Physician profile
Sunil Kumar Srinivas
NPI 1124483292
$7,616.45
in general payments reported to CMS, 2019-2025
9 companies · $1,024 in 2025
The $1,024 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $6,592 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,057 · Food and Beverage: $2,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,056.95 |
| Food and Beverage | $2,559.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,997.34 | 2024 | Ruby Coil, Indigo System, Penumbra System |
| Medtronic, INC. | $1,674.98 | 2024-2025 | Micra, In.Pact Admiral |
| Boston Scientific Corporation | $1,440.55 | 2024-2025 | Versacross Access Solution, Avvigo Guidance System, Watchman |
| W. L. Gore & Associates, INC. | $915.11 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Shockwave Medical, INC | $279.65 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $221.61 | 2024-2025 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $34.18 | 2025 | Gattex |
| Asahi Intecc USA, INC. | $32.66 | 2024 | Peripheral Vascular |
| Ardelyx, INC. | $20.37 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Srinivas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.